FDA Approves Botox Challenger Daxxify for Frown Lines
DaxibotulinumtoxinA-lanm is the first and only peptide-formulated neuromodulator to reduce frown lines, with results lasting longer than conventional neuromodulators, according to the manufacturer.
Chestnut Hill United States Jeffrey Dover Drug Administration Revance Therapeutics Skincare Physicians
Source: medscape.com